Determination of the optimal sample size for a clinical trial accounting for the population size.

Stallard, Nigel; Miller, Frank; Day, Simon; Hee, Siew Wan; Madan, Jason; Zohar, Sarah; Posch, Martin

Stallard, Nigel; Miller, Frank; Day, Simon; Hee, Siew Wan; Madan, Jason; Zohar, Sarah; Posch, Martin.

Afiliación

Stallard N; Statistics and Epidemiology, Division of Health Sciences, Warwick Medical School, University of Warwick, Coventry, CV4 7AL, UK.
Miller F; Department of Statistics, Stockholm University, Stockholm, Sweden.
Day S; Clinical Trials Consulting and Training Limited, Buckingham, UK.
Hee SW; Statistics and Epidemiology, Division of Health Sciences, Warwick Medical School, University of Warwick, Coventry, CV4 7AL, UK.
Madan J; Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK.
Zohar S; INSERM, U1138, team 22, Centre de Recherche des Cordeliers, Université Paris 5, Université Paris 6, Paris, France.
Posch M; Section of Medical Statistics, CeMSIIS, Medical University of Vienna, Austria.

Biom J ; 59(4): 609-625, 2017 Jul.

Article en En | MEDLINE | ID: mdl-27184938

Asunto(s)

Ensayos Clínicos como Asunto/métodos; Densidad de Población; Teorema de Bayes; Humanos; Distribución de Poisson; Tamaño de la Muestra

Palabras clave

Bayesian; Clinical trial design; Decision theory; Exponential family form; Optimal sample size

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Ensayos Clínicos como Asunto / Densidad de Población Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Biom J Año: 2017 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google